Adaptiiv and St. Jude Children’s Research Hospital agree to collaboration partnership to advance proton radiation therapy treatment
August 15, 2019
Halifax, NS, July 3, 2019 – Adaptiiv Medical Technologies Inc. (Adaptiiv) is pleased to announce that St. Jude Children’s Research Hospital, Inc. (St. Jude) has become its latest Collaboration Partner. The two organizations have agreed to work together to develop a module in Adaptiiv’s 3D Bolus software to produce patient-specific proton therapy range shifters. The work being undertaken will further advance proton treatments, aiming to improve current techniques that could result in the additional sparing of healthy tissues.
St. Jude is leading the way the world understands, treats and defeats childhood cancer and other life-threatening diseases. As a cutting-edge research institution, world-class children’s hospital, and America’s largest healthcare charity, St. Jude is dedicated to finding cures and saving children’s lives by leading the way the world understands, treats and defeats childhood cancer and other life-threatening diseases.
Adaptiiv’s 3D Bolus software provides practitioners with a turnkey software solution that enables 3D printing of patient-specific accessories for use in radiation therapy. Accessories created using Adaptiiv’s solution conform to patient anatomy, improving dose delivery and patient experience. Patients are more comfortable throughout the treatment period and because the software fully integrates with a cancer center’s treatment planning system, set-up and production times are drastically reduced.
Innovation Leaders in Radiation Oncology
“We are pleased to collaborate with forward-minded organizations, such as St. Jude, one of the world’s foremost pediatric radiation therapy centers,” says Adaptiiv CEO, Peter Hickey. “We are demonstrating new, innovative approaches to cancer treatment including the development and evaluation of patient-specific proton treatment techniques using 3D printed medical accessories.”
Adaptiiv Medical Technologies Inc. is the definitive software platform to design 3D printed medical accessories for use in radiation oncology. Headquartered in Halifax, Nova Scotia, Canada, Adaptiiv is shaping the future of patient-specific healthcare through innovation and collaboration with leading cancer centers throughout the world. Adaptiiv is the first company in the world to receive US FDA 510(k) clearance to market a 3D printing software solution intended for use in radiation oncology. Adaptiiv’s 3D printing software solution is currently being used in eleven countries.